An overdose with nivolumab is unlikely and has not been described in the clinical trials. There is no specific treatment for the overdose of nivolumab. It is, therefore, of paramount importance to ensure proper dosage and administration intervals of this drug. In case of an overdose, the patient should be placed under strict monitoring, and immediate symptomatic treatment should be provided as soon as signs of adverse reactions occur.